Julie Bockenstette
Executive at Acumen Pharmaceuticals (NASDAQ: ABOS)
Indianapolis, Indiana, United States
Find your path to Julie
45 people in our graph share verified history with Julie β schools, employers, funds. One of them is your warm intro.
Yuto ToriiunlockedJulie: together at Elanco (2018)
Γ7Julie: together at University of Cincinnati Carl H. Lindner College of Business
Γ4Julie: together at Elanco
Executive at Acumen Pharmaceuticals (NASDAQ: ABOS)
Intro paths
β
In turn, Julie can intro founders to Acumen Pharmaceuticals (NASDAQ: ABOS)'s investors below.
Acumen Pharmaceuticals (NASDAQ: ABOS)'s investors Β· 2
Experience
- Acumen Pharmaceuticals, Inc.Chief People Officercurrent2026 β presentIndianapolis, Indiana, United States
- Acumen Pharmaceuticals, Inc.Executive Vice President, Head of HR2021 β 2025Indianapolis, Indiana
- Joy's House Adult Day ServiceBoard Membercurrent2024 β presentIndianapolis, Indiana
- Integrating Women Leaders FoundationBoard Chair2019 β 2023Indianapolis, Indiana
- RocheVP of People & Culture - North America & Europe2019 β 2021Fishers, Indiana
- RocheHR Senior Director - North America2018 β 2019Fishers, Indiana
- ElancoHead of HR - North America & Global Capabilities2015 β 2018Greenfield, Indiana
- Eli Lilly and CompanyHR Director - Implementation Leader2014 β 2015Cork, Ireland
- Eli Lilly and CompanyHR Director - Implementation Leader2013 β 2014Indianapolis, Indiana
- Eli Lilly and CompanyDistrict Sales Manager2011 β 2013Cincinnati, Ohio
- Eli Lilly and CompanyGlobal Compensation Consultant2008 β 2011Indianapolis, Indiana
- Eli Lilly and CompanyHuman Resources Consultant2006 β 2008Indianapolis, Indiana
- Eli Lilly and CompanyExecutive Sales Representative2000 β 2006Cincinnati, Ohio
Skills & more
Cross-functional Team Leadership25Talent Management13Change Management9Pharmaceutical Industry34Employee RelationsEmployee Engagement1Strategic Human Resources Leadership1Change Leadership2Sales Effectiveness19Diversity & Inclusion1People ManagementCompensation
+8 more
Pharmaceutical SalesHR OperationsStrategic Planning & ExecutionProject ManagementSuccession PlanningHuman Resources Information Systems (HRIS)Executive LeadershipHuman Resource PlanningFrom Julie's professional profile.
Frequently asked questions
- Who is Julie Bockenstette?
- Founder at Acumen Pharmaceuticals (NASDAQ: ABOS)
- Where did Julie Bockenstette go to school?
- Julie Bockenstette studied at University of Cincinnati Carl H. Lindner College of Business (Bachelor of Business Administration (B.B.A.), Marketing & Business Management).
Same school
Also attended University of Cincinnati Carl H. Lindner College of Business31
Shashank SaxenaInvestor at Sierra VenturesAndreas GallikerChief Financial Officer at Mercury FundElizabeth EdwardsFounder of H Venture Partners, incubating microbiome science into consumer brandsChris HjelmPartner at Connetic VenturesKip KnightOperating Partner at Thomvest VenturesRichard FangManaging Partner and Founder at Hunniwell Lake Ventures LLC
+ 25 more
Shared employers
Also worked at Acumen Pharmaceuticals, Inc.4
Also worked at Roche229
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 223 more
Also worked at Elanco13
Jules D'AssonvilleCo-Founder at InnoCom Bio EquitiesChris PatersonVenture Partner at Tall Grass VenturesAlejandro MazaVenture Partner at NazcaLauren HoltvoigtAssociate at Digitalis VenturesYuto ToriiPrincipal at Keio Innovation InitiativeAleta KnowlesInvestment Manager - Biotechnology at UniSeed Pty Ltd.
+ 7 more
Also worked at Eli Lilly and Company189
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital
+ 183 more































